ROTH IRIS (Chief Operating Officer) received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/2/2023ACC: 0001725160-23-000050
Officer· Chief Operating Officer
Since Feb 2023
+350K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
350K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+52.50K
Price / share
—
Trade value
—
% of position
New position
3/1/2023
0.00→52.50K
Total
Net shares
+52.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2023 | A · Award | +52.50K | — | — | New position | 0.00 | 52.50K |
| Total | +52.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
297.50K shares
Shares
+297.50K
Strike price
18.87
Held after
297.50K
Exercisable
—
3/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock297.50K shares | 3/1/2023 | A · Award | +297.50K | 18.87 | — | 297.50K |